Literature DB >> 7369747

Cutaneous hypermelanosis and intramelanotic lipid droplets.

J P Ortonne, H Perrot, D Schmitt, P Bioulac.   

Abstract

Intramelanocytic lipid droplets have been observed in 12 patients with different types of hypermelanosis of the skin. These include drug-induced hypermelanosis, hypermelanosis secondary to use of physical agents, hypermelanotic morphea, generalized scleroderma with diffuse hypermelanosis, a hyperkeratotic tumor in xeroderma pigmentosum, aberrant mongolian spot, and methoxsalen-ultraviolet-A-induced hypermelanosis. Lipid storage was selectively observed in melanocytes. Most of the melanocytes with lipid vacuoles showed ultrastructural signs of hyperactive melanosome synthesis and certain cytoplasmic abnormalities such as melanosomal autophagic vacuole formation and mitochondrial alterations. The importance and the origin of the lipid droplets remain unclear.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7369747

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  A semiquantitative light and electron microscopic analysis of histopathologic changes in photochemotherapy-induced freckles.

Authors:  L Kanerva; K M Niemi; J Lauharanta
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

2.  Café au lait spots in ataxia-telangiectasia (A.T.). Histochemical and ultrastructural study in one case.

Authors:  J P Ortonne; A L Claudy; F Freycon
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

3.  Xeroderma pigmentosum. Ultrastructural study with special reference to abnormalities of the melanin pigmentary system.

Authors:  H Perrot; J P Ortonne
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

4.  Experiences of psychotherapists working with refugees in Germany: a qualitative study.

Authors:  Baye Berihun Asfaw; Claudia Beiersmann; Verena Keck; Christoph Nikendei; Janine Benson-Martin; Inken Schütt; Julia Lohmann
Journal:  BMC Psychiatry       Date:  2020-12-11       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.